This suggests that cjoc42 derivatives inhibit the protein–protein interactions between Gankyrin and certain TSPs that would otherwise allow for the degradation of these proteins and thereby shift the balance towards cancer proliferation. The gene discussed is PSMD10; the disease is cancer.